Shingles Vaccine

Immunogenicity and safety study of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A when co-administered with Pneumovax 23™ in adults aged 50 years and older.

Register Today!

Trial Information

Start DateOngoing
Trial Duration14 Months
Number of Visits5 - 6
Lead CRCJessica Richer
End DateTBD

For additional information
on this trial contact: